U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06970951) titled 'Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases' on May 06.
Brief Summary: This clinical trial is designed as a single - arm, open - label, single - center, investigator - initiated early - phase clinical study. The primary objective is to evaluate the safety of UTAA91 injection in treating subjects with relapsed/refractory autoimmune inflammatory diseases (AID).
Study Start Date: May 18
Study Type: INTERVENTIONAL
Condition:
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Dry Syndrome
Idiopathic Inflammatory Myopathies
Systemic Sclerosis
Intervention:
BIOLOGICAL: UTAA91 in...